When CEO Michael Pearson of Valeant Pharmaceuticals International Inc. said in April that "the Middle East and North Africa [together] is going to be a great market," he might have been predicting his firm's $800 million takeover of Amoun Pharmaceutical Co. S.A.E., Egypt's biggest pharma firm, with a powerful presence in the region.